By Gina Lee
Investing.com – The dollar rose on Friday morning in Asia, ending the week with its best performance since April.
The that tracks the greenback against a basket of other currencies gained 0.10% to 100.638 by 11:24 AM ET (4:24 AM GMT). The release of “horrible” economic data overnight caused investors to turn to the greenback, viewed as a safe haven.
The U.S. reported 4.427 million for the past week overnight, with an unprecedented 26 million people losing their jobs since late March.
Meanwhile, the Financial Times said on Thursday that Gilead Sciences’ (NASDAQ:) antiviral drug remdesivir failed its first randomized clinical trials.
The company was testing the drug’s efficacy in treating the COVID-19 virus and have denied that the tests were a flop.
But news of the failure was enough to spook investors, who were closely watching the trial’s progress.
“I’m running with a more bearish story for the next two or three weeks,” Westpac FX analyst Imre Speizer told CNBC.
“The economic data is going to be horrible. I’m betting that markets will be shocked by it, even though we know it’s coming, and that will cause risk sentiment to fall.”
The pair was up 0.07% to 107.66 as the Bank of Japan said earlier in the day that it could replace its government bond-purchase target to allow unlimited buying.
The pair lost 0.13% to 0.6359 and the pair lost 0.22% to 0.5993 as stocks’ losses decreased investors’ appetite for the Antipodean risk currencies.
The pair gained 0.25% to 7.0831. The pair reversed earlier losses to gain 0.07% to 1.2351, even as Bank of England official Jan Vlieghe stated overnight, “It seems that we are experiencing an economic contraction that is faster and deeper than anything we have seen in the past century, or possibly several centuries.”
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.